查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1950444

颈动脉分流器市场按产品类型、材料、设计、技术、最终用户和分销管道划分，全球预测（2026-2032）

Carotid Artery Shunt Market by Product Type, Material, Design, Technology, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年颈动脉分流市场价值为 2.0568 亿美元，预计到 2026 年将成长至 2.2825 亿美元，预计到 2032 年将达到 4.5037 亿美元，复合年增长率为 11.84%。

关键市场统计数据
基准年 2025 2.0568亿美元
预计年份：2026年 2.2825亿美元
预测年份 2032 4.5037亿美元
复合年增长率 (%) 11.84%

颈动脉分流术的临床作用和采购要求权威概述：影响器械选择和手术结果的因素

颈动脉分流器在神经血管和血管外科手术中发挥着至关重要的作用，它能在颈动脉介入治疗期间维持脑血流。随着手术技术的不断发展，临床医生和采购团队都在寻求兼具血流动力学可靠性、易于植入以及与辅助监测技术相容性的装置。该领域的特点是注重患者安全、高效的手术室工作流程以及能够无缝整合到现有手术通讯协定中的装置。

新兴的临床趋势、法规环境以及流通结构的变化正在重塑颈动脉分流产品在医疗保健领域的开发和应用。

颈动脉分流术的最新趋势反映了血管外科和医疗设备商业化领域的更广泛变化。微创手术和混合手术室的兴起拓展了颈动脉介入治疗的进行场所，迫使器械製造商针对不同的手术环境优化分流器的设计。同时，临床医生正在采用能够提供即时血流和压力回馈的整合监测技术，这也影响着产品的设计和采购策略。

2025年关税政策引发的供应链重组和筹资策略调整将如何影响颈动脉介入装置的供应、定价和采购选择

2025年美国关税政策为依赖全球采购的医疗设备製造商、经销商和医疗保健系统带来了新的挑战。製造商面临迫在眉睫的成本压力，被迫重新评估供应商合约、零件筹资策略和库存管理实务。为此，许多机构加快了区域供应商的资格认证，并重组了采购协议，以降低跨境成本波动带来的风险。

详细的细分揭示了最终用户画像、产品类型、分销模式以及材料和技术选择如何驱动不同的采用模式。

关键細項分析揭示了不同使用者群体、产品组合、分销管道、材料、设计选择和底层技术的需求驱动因素和采用模式的差异。按最终用户划分，市场涵盖门诊手术中心、诊所和医院，其中医院进一步细分为教学医院和社区医院。这种分层表明，教学医院倾向于主导具有先进监测功能的设备，而社区医院则优先考虑易用性和经济高效的标准解决方案。依产品类型划分，分流器分为直通式分流器和标准腔分流器，直通式分流器又根据 Pruitt Inahara 和 Sundt 等设计进一步细分，而标准腔分流器则根据 Argyle 和 Javid 等产品类型进行分类。这些区分至关重要，因为直通式设计越来越多地与整合监测功能相结合，而标准腔分流器在以简单性和成熟的临床应用为优先考虑的领域仍然更受欢迎。

临床实务、采购架构和管理体制的区域差异将影响全球市场采纳的速度和打入市场策略。

区域趋势揭示了影响医疗设备应用和策略重点的显着的临床、监管和商业特征。在美洲，医疗保健系统往往更加一体化，采购框架集中化，并更加重视临床医生在产品选择中的影响力，从而创造出以实证医学和价值论证为关键的环境。同时，欧洲、中东和非洲的监管体係错综复杂，采购模式多样，其报销政策和区域製造伙伴关係将对分销策略和产品在地化产生重大影响。亚太地区则兼具高运作的公立医院和快速现代化的私立医疗网络，从而在对技术先进的医疗设备的需求和注重成本效益的选择之间取得了平衡。

差异化的设备特性、临床证据项目、伙伴关係和服务模式将重塑竞争格局，进而影响采购和临床应用。

颈动脉分流术领域的竞争格局主要由产品差异化、实证医学证据以及为临床团队提供的主导支援所驱动。成熟的医疗设备公司和专业血管产品製造商与专注于特定领域设计改进或整合监测功能的小规模创新企业竞争。在高度紧急的医疗环境中，手术效果和安全性是关键的决策标准，因此，那些将器械创新与可靠的临床数据和强大的上市后支援相结合的公司往往更容易获得市场认可。

针对製造商和医疗系统的实际策略重点，应关注产品互通性、弹性采购、实证应用和适应性商业模式。

产业领导者应优先进行一系列协作，将产品创新、供应链韧性和临床合作相结合，以加速产品上市并降低营运风险。首先，设计和开发策略应强调与术中监测系统的互通性，并优先考虑以使用者为中心的功能，例如缩短插入时间和减少血管损伤。其次，供应链策略应包括多元化的采购管道、评估区域製造地，并调整库存调整週期以应对地缘政治因素和关税的衝击。

采用严谨的混合方法调查方法，结合临床医生访谈、监管审查和多学科检验，以得出可操作的策略见解。

我们的研究方法结合了结构化的初步调查（受访者包括临床医生、采购人员和行业高管）和系统的二次研究（包括同行评审文献、监管资料库、临床指南和已发表的技术文件）。初步访谈旨在捕捉关于设备易用性、术中监测偏好和采购决策驱动因素的细緻观点，而二次资讯则为临床实践模式和监管考量提供了背景基础。

综合分析了临床效用、技术完整性和供应链韧性与永续应用和设备长期影响之间的关联。

总而言之，颈动脉分流术市场正处于一个转折点，其驱动因素包括临床对安全性和手术效率的需求、监测技术的进步以及分销和采购格局的变化。能够根据实际工作流程调整设备设计并优先考虑互通性和临床医生培训的製造商，将更有利于在学术机构和社区医疗机构中获得广泛应用。同样，供应链的韧性和适应性强的商业模式对于在应对地缘政治和关税相关干扰的同时维持服务水准至关重要。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 颈动脉分流器市场（依产品类型划分）

  • 直通式分流器
  • 标准管腔分流术

9. 按材料分類的颈动脉分流器市场

  • 聚氯乙烯
  • 硅酮

10. 颈动脉分流术市场设计

  • 闭型
  • 开放型

第十一章 颈动脉分流术市场（依技术划分）

  • 综合监测
    • 流量监测
    • 压力监测
  • 标准

第十二章 颈动脉分流市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 医院
    • 大学医院
    • 社区医院

第十三章 颈动脉分流市场（依通路划分）

  • 直销
  • 经销商
    • 集团采购组织
    • 独立经销商

第十四章 颈动脉分流市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 颈动脉分流市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国颈动脉分流市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国颈动脉分流市场

第十八章：中国颈动脉分流市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Bentley InnoMed GmbH
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CryoLife, Inc.
  • Halyard Health, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • JOTEC GmbH
  • LeMaitre Vascular, Inc.
  • Maquet Cardiovascular LLC
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Stryker Corporation
  • Synovis Micro Companies Alliance, Inc.
  • Teleflex Incorporated
  • Terumo Aortic
  • Terumo Corporation
  • Vascular Solutions LLC
  • WL Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-4F7A6D4FD86A

The Carotid Artery Shunt Market was valued at USD 205.68 million in 2025 and is projected to grow to USD 228.25 million in 2026, with a CAGR of 11.84%, reaching USD 450.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 205.68 million
Estimated Year [2026] USD 228.25 million
Forecast Year [2032] USD 450.37 million
CAGR (%) 11.84%

An authoritative overview of carotid artery shunt clinical roles and procurement imperatives shaping device selection and procedural outcomes

Carotid artery shunts play a critical role in neurovascular and vascular surgery by preserving cerebral perfusion during carotid interventions. As procedural pathways evolve, clinicians and procurement teams demand devices that combine hemodynamic reliability, ease of insertion, and compatibility with adjunct monitoring technologies. The landscape is characterized by an emphasis on patient safety, streamlined operating-room workflows, and devices that integrate seamlessly into existing surgical protocols.

Moving forward, the interplay between clinical adoption and device innovation will determine which products achieve widespread utilization. Clinicians increasingly prioritize characteristics such as rapid deployability, minimal vessel trauma, and compatibility with intraoperative monitoring. Consequently, decision-makers must balance clinical evidence, hospital procurement dynamics, and supply chain considerations when selecting shunt options for carotid procedures.

Emerging clinical, regulatory, and distribution dynamics that are reshaping carotid shunt product development and adoption across care settings

Recent shifts in the carotid shunt landscape reflect broader changes across vascular surgery and medical device commercialization. Minimally invasive approaches and hybrid operating rooms have broadened the settings in which carotid interventions occur, prompting device makers to optimize shunt profiles for diverse procedural environments. Concurrently, clinicians are embracing integrated monitoring technologies that provide real-time flow and pressure feedback, which in turn influences product design and purchasing preferences.

Regulatory emphasis on device safety and post-market surveillance has also altered how manufacturers approach clinical validation and labeling. In parallel, supply chain modernization and strategic partnerships between manufacturers and group purchasing entities have reconfigured distribution pathways. Taken together, these trends indicate a period of accelerated evolution in which clinical utility, regulatory compliance, and distribution agility collectively determine commercial success.

How 2025 tariff measures triggered supply chain realignments and procurement strategies that affect availability, pricing, and sourcing for carotid devices

The imposition of tariffs in the United States during 2025 introduced a new layer of complexity for medical device manufacturers, distributors, and health systems that rely on global sourcing. Manufacturers faced immediate cost pressures that prompted reassessments of supplier contracts, component sourcing strategies, and inventory management practices. In response, many organizations accelerated regional supplier qualification and restructured procurement agreements to mitigate exposure to cross-border cost volatility.

These tariff-related disruptions also influenced pricing negotiations between manufacturers and healthcare purchasers, with longer procurement cycles and heightened scrutiny of total cost of ownership. At the same time, some manufacturers intensified efforts to localize production or diversify their manufacturing footprint to maintain margin integrity while preserving product availability for clinical pathways. Ultimately, the tariff environment reinforced the importance of supply chain resilience, transparent supplier relationships, and proactive scenario planning for contingency sourcing and inventory buffer strategies.

Granular segmentation reveals how end user profiles, product typologies, distribution models, and material and technology choices drive differentiated adoption patterns

Key segmentation insights illuminate how demand drivers and adoption patterns differ across distinct user groups, product configurations, distribution channels, materials, design choices, and enabling technologies. Based on end user, the market is studied across ambulatory surgical centers, clinics, and hospitals, with hospitals further distinguished between academic medical centers and community hospitals; this stratification reveals that academic centers often lead adoption of advanced monitoring-enabled devices, while community hospitals prioritize ease of use and cost-efficient standard solutions. Based on product type, the market is studied across flow through shunts and standard luminal shunts, with flow through shunts further classified by designs such as Pruitt Inahara and Sundt, and standard luminal shunts further typified by offerings like Argyle and Javid; these distinctions matter because flow through designs are increasingly paired with integrated monitoring while standard luminal designs remain preferred where simplicity and established clinical familiarity are prioritized.

Based on distribution channel, the market is studied across direct sales and distributors, with distributors further segmented into group purchasing organizations and independent distributors; this distribution breakdown highlights divergent go-to-market strategies where direct sales enable close clinical engagement and customized training, whereas distributor-led channels deliver scale and purchasing efficiencies. Based on material, the market is studied across polyvinyl chloride and silicone, each offering trade-offs between flexibility, kink resistance, and sterilization compatibility-choices that can affect clinician preference and inventory policies. Based on design, the market is studied across closed ended and open ended constructs, with open ended options offering certain access advantages while closed ended designs may simplify flow control. Based on technology, the market is studied across integrated monitoring and standard solutions, with integrated monitoring further categorized into flow monitoring and pressure monitoring; this technological segmentation underscores an emergent bifurcation between devices that provide actionable intraoperative metrics and those that focus solely on luminal patency, which in turn shapes clinical protocols and purchasing criteria.

Regional variations in clinical practice, procurement frameworks, and regulatory regimes that determine pace of adoption and go-to-market approaches across global markets

Regional dynamics exhibit distinct clinical, regulatory, and commercial characteristics that influence device uptake and strategic priorities. In the Americas, health systems often emphasize consolidation, centralized procurement frameworks, and strong clinician influence in product selection, creating an environment where evidence generation and value demonstration become pivotal to adoption. In contrast, Europe, Middle East & Africa encompasses a broad regulatory mosaic and diverse purchasing models, where reimbursement policies and regional manufacturing partnerships can materially affect distribution strategies and product localization. Meanwhile, Asia-Pacific presents a combination of high-volume public hospitals and rapidly modernizing private networks, resulting in varied demand for technologically advanced devices alongside cost-sensitive options.

Across all regions, regulatory compliance, clinical training infrastructure, and local manufacturing capabilities shape how quickly new shunt technologies move from introduction to routine use. Consequently, manufacturers and purchasers must tailor market entry and scale-up plans to align with regional reimbursement models, clinician training pathways, and supply chain realities, leveraging partnerships that accelerate clinical validation and procurement alignment.

Competitive landscape shaped by differentiated device features, clinical evidence programs, partnerships, and service models that influence procurement and clinical uptake

Competitive dynamics in the carotid shunt landscape are driven by product differentiation, evidence generation, and service-led support for clinical teams. Established medical device firms and specialist vascular product manufacturers compete alongside smaller innovators that focus on niche design enhancements or integrated monitoring capabilities. Firms that pair device innovation with robust clinical data and strong post-market support tend to achieve greater traction in high-acuity settings where procedural outcomes and safety are primary decision criteria.

Partnerships between device manufacturers and hospital systems or group purchasing organizations have become increasingly important to secure procurement pathways and to co-develop clinical training programs. In addition, strategic collaborations with manufacturers of intraoperative monitoring platforms enhance the clinical value proposition of shunt devices. Firms that invest in surgeon education, multi-disciplinary engagements, and responsive aftermarket logistics are better positioned to support long-term adoption and to adapt to evolving clinical protocols.

Practical strategic priorities for manufacturers and health systems focusing on product interoperability, resilient sourcing, evidence-based adoption, and adaptive commercial models

Industry leaders should prioritize a coordinated set of actions that link product innovation, supply chain resilience, and clinical engagement to accelerate adoption and mitigate operational risk. First, design and development strategies should emphasize interoperability with intraoperative monitoring systems and prioritize user-centered features that reduce insertion time and vessel trauma. Second, supply chain strategies must include multi-sourcing options, regional manufacturing assessments, and inventory cadence adjustments to withstand geopolitical and tariff-driven disruptions.

Third, clinical adoption should be supported by pragmatic evidence-generation plans that combine real-world data collection with targeted clinical training to shorten the learning curve. Fourth, commercial models ought to balance direct engagement with hospitals and partnerships with distributor networks to reconcile the need for clinical support with the efficiencies of scaled distribution. Finally, organizations should develop flexible pricing and contracting constructs that accommodate value-based procurement conversations and that align incentives across clinicians, hospitals, and payers to foster durable adoption.

A rigorous mixed-methods research design integrating clinician interviews, regulatory review, and multi-source validation to support actionable strategic insights

The research approach combined structured primary engagements with clinicians, procurement leaders, and industry executives alongside systematic secondary research across peer-reviewed literature, regulatory databases, clinical guidelines, and publicly available technical documentation. Primary interviews were designed to capture nuanced perspectives on device usability, intraoperative monitoring preferences, and procurement decision drivers, while secondary sources provided contextual grounding on clinical practice patterns and regulatory considerations.

Data synthesis emphasized triangulation of insights, cross-validating clinician-reported preferences with distribution channel feedback and manufacturing perspectives. Segmentation frameworks were developed iteratively to reflect differences in end users, product types, distribution channels, materials, design choices, and enabling technologies. Quality assurance processes included peer review, consistency checks, and sensitivity analyses to ensure that findings are robust and practically relevant for commercial planning and clinical strategy development.

Consolidated conclusions tying clinical utility, technological integration, and supply chain resilience to sustainable adoption and long-term device impact

In summary, the carotid shunt landscape is at an inflection point driven by clinical demand for safety and procedural efficiency, technological advances in monitoring, and evolving distribution and procurement dynamics. Manufacturers that align device design with real-world clinical workflows and prioritize interoperability and clinician training will be better positioned to secure adoption in both academic and community settings. Likewise, supply chain resilience and adaptive commercial models are essential to manage geopolitical and tariff-related disruptions while maintaining service levels.

As stakeholders navigate this environment, the combined emphasis on clinical evidence, operational reliability, and collaborative commercialization will determine which products achieve sustainable integration into surgical practice. Decision-makers should therefore adopt a cross-functional approach that ties clinical validation to procurement strategy and supply chain contingency planning to accelerate safe, effective, and cost-aware adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Carotid Artery Shunt Market, by Product Type

  • 8.1. Flow Through Shunts
  • 8.2. Standard Luminal Shunts

9. Carotid Artery Shunt Market, by Material

  • 9.1. Polyvinyl Chloride
  • 9.2. Silicone

10. Carotid Artery Shunt Market, by Design

  • 10.1. Closed Ended
  • 10.2. Open Ended

11. Carotid Artery Shunt Market, by Technology

  • 11.1. Integrated Monitoring
    • 11.1.1. Flow Monitoring
    • 11.1.2. Pressure Monitoring
  • 11.2. Standard

12. Carotid Artery Shunt Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals
    • 12.3.1. Academic Medical Centers
    • 12.3.2. Community Hospitals

13. Carotid Artery Shunt Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
    • 13.2.1. Group Purchasing Organizations
    • 13.2.2. Independent Distributors

14. Carotid Artery Shunt Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Carotid Artery Shunt Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Carotid Artery Shunt Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Carotid Artery Shunt Market

18. China Carotid Artery Shunt Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. B. Braun Melsungen AG
  • 19.7. Baxter International Inc.
  • 19.8. Becton, Dickinson and Company
  • 19.9. Bentley InnoMed GmbH
  • 19.10. Boston Scientific Corporation
  • 19.11. Cardinal Health, Inc.
  • 19.12. CryoLife, Inc.
  • 19.13. Halyard Health, Inc.
  • 19.14. Integra LifeSciences Corporation
  • 19.15. Johnson & Johnson
  • 19.16. JOTEC GmbH
  • 19.17. LeMaitre Vascular, Inc.
  • 19.18. Maquet Cardiovascular LLC
  • 19.19. Medtronic plc
  • 19.20. Merit Medical Systems, Inc.
  • 19.21. Stryker Corporation
  • 19.22. Synovis Micro Companies Alliance, Inc.
  • 19.23. Teleflex Incorporated
  • 19.24. Terumo Aortic
  • 19.25. Terumo Corporation
  • 19.26. Vascular Solutions LLC
  • 19.27. W. L. Gore & Associates, Inc.
  • 19.28. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CAROTID ARTERY SHUNT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CAROTID ARTERY SHUNT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW THROUGH SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW THROUGH SHUNTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW THROUGH SHUNTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD LUMINAL SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD LUMINAL SHUNTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD LUMINAL SHUNTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLOSED ENDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLOSED ENDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLOSED ENDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY OPEN ENDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY OPEN ENDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY OPEN ENDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY PRESSURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY PRESSURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY PRESSURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 160. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 164. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 166. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 168. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 190. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 194. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 196. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 200. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 203. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 204. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 206. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)